PRESS RELEASE - CEC CAPITAL

Gensciences Group Raises Over RMB 800 Million in Consecutive Series A and B Financings, CEC Capital Group Served as Exclusive Financial Advisor

2021-03-04
YS Biopharma Raises $130 Million in Series B Financing, CEC Capital Group Served as Exclusive Financial Advisor.

2021-02-24
WuXi Diagnostics Rasies $150 Million in Series B Financing, CEC Capital Group Served as Exclusive Financial Advisor

2021-02-24
Sinotau Pharmaceutical Raises Series D Financing, CEC Capital Group Served as Exclusive Financial Advisor.

2021-02-23
VisionSeq Raises RMB 200 Million in Series C Financing, CEC Capital Group Served as Exclusive Financial Advisor

2021-02-04
Nubo Med Raises Series B Financing of Several Hundreds Million RMB, CEC Capital Group as Exclusive Financial Advisor

2021-02-02
CEC Capital Group-backed Enterprise MeiShang Raises RMB 400 Million in New Financing.

2021-01-30
4Paradigm Raises $700 Million in Series D Financing, CEC Capital Group Served as Financial Advisor

2021-01-23
Cothera Bioscience Raises Series B Financing, CEC Capital Group Served as Exclusive Financial Advisor.

2021-01-19
WeRide, a CEC Capital Group portfolio company, completes Series B1 financing round of USD 200 million

2021-01-14

<

...

7
8
9
10
11
12

...

>

Media Contacts

CHINA

Bonnie Guo

Tel：+86 (10) 8519 2080

Fax：+86 (10) 8519 2078

bonnie.guo@ceccapitalgroup.com

Social Media